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The etiology of testicular germ cell tumors (TGCTs) is poorly understood. Recent
epidemiological findings suggest that, TGCT risk is determined very early in life, although
the available data are still conflicting. The rapid growth of the testes during puberty may
be another period of vulnerability. Body size has received increasing attention as possible
risk factor for TC. To clarify the relation of body size and its anthropometric variables to
TGCT risk, the authors analyzed data from 272 cases and 382 controls with regard to
height (cm), weight (Kg), and body mass index (BMI; kg/m2). Overall, participants in the
highest quartile of height were more likely to be diagnosed with TGCTs than participants in
the lowest quartile of height, OR 2.22 (95% confidence intervals (CI): 1.25–3.93; adjusted;
ptrend = 0.033). Moreover, histological seminoma subgroup was significantly associated
with tallness, very tall men (>182 cm) having a seminoma TGCT risk of OR = 2.44
(95% confidence intervals (CI): 1.19–4.97; adjusted; ptrend = 0.011). There was also a
significant inverse association of TGCT with increasing BMI (ptrend = 0.001; age-adjusted
analysis) and this association was equally present in both histological subgroups. These
preliminary results indicate that testicular cancer (TC) is inversely associated with BMI and
positively associated with height, in particular with seminoma subtype. Several studies
have reported similar findings on body size. As adult height is largely determined by
high-calorie intake in childhood and influenced by hormonal factors at puberty, increased
attention to postnatal exposures in this interval may help elucidate the etiology of TGCTs.
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INTRODUCTION
Testicular cancer (TC) is the most common type of malignancy
in men aged 15–40 years (Dieckmann and Pichlmeier, 2004). The
incidence of TC hasmore than doubled worldwide over the last 40
years in several populations (Purdue et al., 2005; Bray et al., 2006).
The reasons of this rise are not entirely clear (McGlynn and Cook,
2009).
Evidence of incidence peak of TC among young adults sug-
gests that causal factors operate very early in life (Bray et al.,
2006). One theory attributes it to the increase in endogenous
estrogen levels during prenatal life and/or later exposures to
various occupational and environmental estrogenic chemicals,
termed endocrine-disrupting chemicals (EDCs) (Toppari et al.,
1996; Sharpe, 2003; Cook et al., 2011; Giannandrea et al., 2011).
According to this hypothesis, these exposures are also risk factors
for other male reproductive disorder, such as cryptorchism and
impaired sperm quality (Skakkebaek et al., 2001; Storgaard et al.,
2006). Recently, it has been suggested that post-natal exposures
might increase the risk of developing TC, and that secretion of
sex hormones, which are involved in the growth and the devel-
opment of the testicle, might be instrumental in TC progression
(James, 2010; Trabert et al., 2011).
One possible risk factor that has received increasing attention
is body size, which is determined by hereditary, nutritional, and
hormonal factors (Dieckmann and Pichlmeier, 2002). Height,
weight, and body mass index (BMI) have been examined in
a number of studies, with mixed results (Lerro et al., 2010).
Several studies have reported inverse associations of TC with BMI
(Petridou et al., 1997; Bjørge et al., 2006; Lerro et al., 2010). A
number of studies have reported that increased adult height may
be a risk factor for TC, thereby suggesting that factors related to
adult height may also be related to risk of these tumors (Richiardi
et al., 2003; Dieckmann et al., 2008; Lerro et al., 2010). One expla-
nation for the height association may be that better childhood
nutrition increases both adult height and risk of TC. This hypoth-
esis is supported by epidemiological observations of constantly
increasing incidence of TC since the beginning of the twentieth
century with the only major interruption in this trend occurring
for men born during World War II or immediately thereafter,
when food availability had been dramatically reduced (Moller,
1989; Aschim et al., 2005; Giannandrea, 2009).
To clarify the relation of anthropometric variables to TGCT
risk and to one another, we analyzed data from 321 cases and 465
controls enrolled at our laboratory with regard to height (cm),
weight (Kg) and body mass index (BMI; kg/m2).
MATERIALS AND METHODS
Participants among 321 consecutive patients affected by TC
and 465 controls were originally selected at the Laboratory
of Seminology, Semen Bank, Department of Experimental
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Controls were recruited among healthy men who underwent to
seminal analyses in order to ascertain their fertility status before
getting married. We excluded men with conditions possibly asso-
ciated with impaired sperm quality, and/or with a history of
neoplastic pathologies to provide the most suitable control group.
Only men aged 20–55 years at diagnosis were eligible for the
study. Inclusion was restricted to this age range as normal height
growth is complete between 16 and 20 years, while there is a
characteristic decline in height growth in adulthood. Some of the
controls who underwent to seminal analyses were men affected
by severe obesity according to WHO classification (WHO, 2000),
and therefore, this group was excluded from both cases and con-
trols in order to avoid the confounding effect of this condition on
our study variables.
Only patients with tumors of germ cell origin were included
in the analyses. We categorized the cases into the two major
histopathologic subgroups: seminomas or non-seminomas,
which include embryonal carcinomas, endodermal sinus tumors,
teratomas, choriocarcinomas, or germ cell tumors of mixed mor-
phology. Our study population was therefore finally restricted to
a total of 272 cases and 382 controls, according to the selection
criteria described above.
Statistical analyses were performed by use of a SPSS statis-
tical package. All tests were two sided, with p < 0.05 defined
as statistically significant. Logistic regression models were calcu-
lated to obtain odds ratios (OR) and 95% confidence intervals
(CIs) with adjustment for the potentially confounding factors,
height, weight, and age at diagnosis (Armitage et al., 2001).
ORs, confidence limits, and p values were adjusted for age
because of imbalance of age distribution between cases and
controls.
Height, weight, and BMI were categorized into quartiles on the
basis of the distribution among the entire study group. Categories
were 20–29 years, 30–34 years, 35–39 years, and ≥40 years with
respect t to age; ≤173 cm, 174–178 cm, 179–182 cm, and >182
with respect to height. BMI [weight (in kilograms) divided by
height (in meters) squared] was calculated for each subject and
categorized into slim (BMI <23.15 kg/m2), normal weight (BMI
23.16–24.97 kg/m2), overweight (BMI 24.98–27.4 kg/m2), and
obese (BMI ≥27.4 kg/m2). Tests for trend were performed by use
of the categorized variables.
RESULTS
The descriptive tabulation of anthropometric measures distribu-
tion of cases and controls is shown in Table 1. The mean ages
of the non-seminoma cases was lower than the mean age of
the seminoma cases (30.6 years, standard deviation (SD): 6.0 vs.
34.1 years, SD: 5.9; p < 0.05). It is well-acknowledged that non-
seminoma peak at younger age than seminoma. Therefore, the
risk of TC decrease with increasing age at diagnosis, with non-
seminomas having a more significant inverse relationship with
age (ptrend < 0.001) than seminomas (ptrend = 0.021) (Table 2).
The relations of anthropometric variables and TC risk are shown
in Table 2. In the multivariate analysis, BMI was inversely asso-
ciated and height was positively associated with risk of TC
(Table 2).
Overall, participants in the highest quartile of height were
more likely to be diagnosed with testicular germ cell tumors
(TGCTs) than participants in the lowest quartile of height, OR
2.22 (95% confidence intervals (CI): 1.25–3.93; adjusted; ptrend =
0.033). Moreover, histological seminoma subgroup was signifi-
cantly associated with tallness, very tall men (>182 cm) having
a seminoma TGCT risk of OR = 2.44 (95% confidence inter-
vals (CI): 1.19–4.97; adjusted; ptrend = 0.011). The multivariate-
adjusted odds ratio for the highest quartile group of BMI relative
to the lowest was 0.42 (95% CI: 0.24–0.75; ptrend = 0.01), with
no difference by histological subtype (Table 2). There was also a
significant inverse association of TGCT with increasing weight
(ptrend = 0.001; age-adjusted analysis) and this association was
equally present in both histological subgroups.
DISCUSSION
These preliminary results indicate that TC is positively associated
with height, in particular with seminoma subtype, and inversely
related with BMI. Therefore, the present study indicated an excess
of tall men in the cohort of patients with TC. To our knowl-
edge, this study is the first to explore the relationship between
tallness and the risk of TC from a southern European country.
Thus far, the majority of studies on tallness in relation to the risk
of TC were conducted in US and Nordic countries (Akre et al.,
2000; McGlynn et al., 2007; Dieckmann et al., 2008; Cook et al.,
2010; Lerro et al., 2010). Measures of adult height, as well as the
incidence rate of TC, resulted both elevated among Scandinavian
populations (Richiardi et al., 2003; Purdue et al., 2005).
Table 1 | Descriptive statistical analysis of anthropometric measures (Mean ± SD).
Patients (n) Age (years) Height (cm) BMI Weight (Kg)
Controls (C) 382 35.7 ± 7.1 177.6 ± 6.5 24.7 ± 2.0 78.1 ± 8.7
All TC (TC) 272 32.4 ± 6.2 177.8 ± 6.3 23.8 ± 2.3 75.5 ± 9.0
Seminoma (S) 138 34.1 ± 5.9 177.5 ± 6.1 24.0 ± 2.5 75.7 ± 9.4
Nonseminoma (NS) 134 30.6 ± 6.0 178.2 ± 6.5 23.6 ± 2.2 75.3 ± 8.6
TC vs. C b a a a
S vs. C a a a a
NS vs. C b a a a
aNot significant.
bp < 0.05.
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Though differences in genetic backgrounds among Scandinavian
and southern European populations exist, these preliminary find-
ings imply that possible postnatal exposures may play an impor-
tant role in determining risk of TC. As adult height is largely
determined during the first 2 years of life, it may be postu-
lated that high calorie nutrition after birth could have a role
in TC pathogenesis (Frankel et al., 1998; McGlynn et al., 2007;
Giannandrea, 2009). In addition, as final adult height is strongly
dependent on testis sex-steroids (Veldhuis et al., 2005) a corre-
lation between height and TC risk may suggest that androgen
secretion during puberty might be involved in TC progression.
One further height-related factor may be insulin-like growth fac-
tor (IGF) and the IGF pathway, which is also involved in the
control of spermatogenesis (Gunnell et al., 2001; Giovannucci
et al., 2004). Increased serum IGF-1 levels were associated with
increased height has also been reported in several studies (Chia
et al., 2008).
Height has been positively associated with risk of TC in the
majority of studies in which it has been examined (Akre et al.,
2000; McGlynn et al., 2007; Dieckmann et al., 2008; Cook et al.,
2010; Lerro et al., 2010). Akre et al. (2000) found a statistically
significant increased risk of TC associated with greater height,
and this association was particularly evident inmen with semino-
mas. Dieckmann et al. (2008) found that very tall men (>195 cm)
carried a TC risk of OR: 3.35 (95% confidence intervals (CI):
2.88–3.90; adjusted). In the STEED Study, increased height was
significantly related to risk of TC (OR: 1.85; CI 95%: 0.71, 1.32)
(McGlynn et al., 2007; Lerro et al., 2010).
A number of studies have so far reported an inverse rela-
tionship between BMI and TGCTs, although the available results
are still conflicting, with some studies reporting null findings
(Petridou et al., 1997; Bjørge et al., 2006; Lerro et al., 2010). A
recent meta-analysis conducted by Lerro et al. (2010) has pro-
duced a tentative evidence that TC risk was inversely associated
with BMI, with a summary OR of 0.92 (95% CI: 0.86–0.98;
p = 0.011). The biological reasons of this negative association
are likely to be more complex of those contemplated to explain
the association of TC with tallness. Some authors have suggested
that lower BMI found in previous studies could also be a math-
ematical artifact as this association may be related to an excess
of tall men in TC cohorts rather than to leanness of the patients
(Dieckmann and Pichlmeier, 2002). This is due to the fact that
height is squared in the denominator of the BMI-formula, low-
ering the numerical calculation of MBI in very tall men at hight
TC risk despite normal weight. However, our study shows addi-
tional significant inverse association of TGCT with increasing
weight (ptrend = 0.001), therefore confuting, at least in part, this
suggestion.
Body size is primarily determined by hereditary, nutritional,
and hormonal factors (Dieckmann and Pichlmeier, 2002). The
hormonal determinants can be divided into growth hormones
and sex hormones. Most previous studies on postnatal risk
factors for TC have focused on endogenous sex hormones.
Obesity is inversely associated with both total testosterone and
sex hormone-binding globulin (Akre et al., 2000). Furthermore,
obese men have increased levels of both estradiol and estrone
coming mostly from extraglandular conversion of androgen pre-
cursors (Akre et al., 2000; Dieckmann and Pichlmeier, 2002).
Since testicular germ cell cancer is probably initiated in utero,
postnatal hormones are likely to function as promoters. These
hormones may continue to exert their effect in advanced stages
of tumor development at time of puberty when the testicles grow
and develop rapidly.
Adult stature can be considered a proxy of childhood nutrition,
although stature is also determined by genetic and hormonal fac-
tors. It has been suggested that the trend of increasing adult height
and the increasing TC incidence are biologically interconnected
with improved nutrition in early life.
In summary, we have found a lower risk of TC among men
with high BMI. Further investigation of this inverse relationship
may be warranted, for which the present results provide only lim-
ited support. Furthermore, tallness was positively associated with
risk of TC. The biologic mechanism suggested is the promotion
of this cancer by sex hormones and/or growth hormones, such as
growth hormone and/or IGF-I.
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